AU2002346423A1 - Atrial natriuretic peptide clearance receptor variant associated with bone disorders - Google Patents

Atrial natriuretic peptide clearance receptor variant associated with bone disorders

Info

Publication number: AU2002346423A1
Authority: AU; Australia
Prior art keywords: natriuretic peptide; atrial natriuretic; bone disorders; receptor variant; variant associated
Prior art date: 2001-11-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002346423A

Other languages

English (en)

Other versions

AU2002346423A8 (en

Inventor

Douglas W. Axelrod

Jonathan S. Cook

Adam Houghton

Neelam Jaiswal

Darren Ji

Lawrence Mertz

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ore Pharmaceuticals Inc

Procter and Gamble Co

Original Assignee

Ore Pharmaceuticals Inc

Procter and Gamble Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-16

Filing date

2002-11-18

Publication date

2003-06-10

2002-11-18 Application filed by Ore Pharmaceuticals Inc, Procter and Gamble Co filed Critical Ore Pharmaceuticals Inc

2003-06-10 Publication of AU2002346423A1 publication Critical patent/AU2002346423A1/en

2003-06-10 Publication of AU2002346423A8 publication Critical patent/AU2002346423A8/xx

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Microbiology (AREA)
Pathology (AREA)
Toxicology (AREA)
Physics & Mathematics (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Endocrinology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU2002346423A 2001-11-16 2002-11-18 Atrial natriuretic peptide clearance receptor variant associated with bone disorders Abandoned AU2002346423A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US33144601P	2001-11-16	2001-11-16
US60/331,446		2001-11-16
PCT/US2002/036858 WO2003044039A2 (fr)	2001-11-16	2002-11-18	Variante de recepteur de clairance du peptide natriuretique auriculaire associee a des troubles osseux

Publications (2)

Publication Number	Publication Date
AU2002346423A1 true AU2002346423A1 (en)	2003-06-10
AU2002346423A8 AU2002346423A8 (en)	2003-06-10

Family

ID=23294005

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002346423A Abandoned AU2002346423A1 (en)	2001-11-16	2002-11-18	Atrial natriuretic peptide clearance receptor variant associated with bone disorders

Country Status (2)

Country	Link
AU (1)	AU2002346423A1 (fr)
WO (1)	WO2003044039A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20070118295A1 (en) *	2005-03-02	2007-05-24	Al-Murrani Samer Waleed Khedhe	Methods and Systems for Designing Animal Food Compositions

2002
- 2002-11-18 WO PCT/US2002/036858 patent/WO2003044039A2/fr not_active Ceased
- 2002-11-18 AU AU2002346423A patent/AU2002346423A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003044039A3 (fr)	2003-12-11
AU2002346423A8 (en)	2003-06-10
WO2003044039A2 (fr)	2003-05-30

Publication	Publication Date	Title
AU2002244305A1 (en)	2002-10-03	Side rail assembly for canopy
AUPR769501A0 (en)	2001-10-11	Cytokine receptor 1
AU2002341834A1 (en)	2003-04-07	Antagonists
AU2002346603A1 (en)	2003-06-10	Polypeptide quantitation
AU2003297462A1 (en)	2004-07-22	Composite motion probing
AU2002303419A1 (en)	2002-11-05	Prosthetic eyelashes
AU2002252460A1 (en)	2002-10-08	Human cytokine receptor
AU2002305944A1 (en)	2002-09-19	Mouse cytokine receptor
AU2003297317A1 (en)	2004-07-09	Defensin-inducing peptides from fusobacterium
AU2002346423A1 (en)	2003-06-10	Atrial natriuretic peptide clearance receptor variant associated with bone disorders
EP1222900A3 (fr)	2003-01-29	Elément de liason pour l'osteosynthese
AU2002367281A1 (en)	2003-07-24	Isolated cytokine receptor licr-2
AU2002322323A1 (en)	2003-01-08	Bioerodible conducting materials
AU2002324476A1 (en)	2003-01-29	Human cytokine receptor
AU2002318513A1 (en)	2003-01-21	Novel neurotrophic factors
WO2002077001A9 (fr)	2013-10-31	Nouveaux recepteurs
AU2002249304A1 (en)	2002-09-19	Novel human gnrh receptor
GB0128161D0 (en)	2002-01-16	Receptor protein
AUPR682801A0 (en)	2001-08-30	Egf receptor 1
AU2002344325A1 (en)	2002-11-25	Isolated human g protein-coupled receptor
AU2002359260A1 (en)	2003-04-22	A human g protein coupled receptor
AU2003260313A1 (en)	2004-02-09	Human gnrh (type 2) receptor
AUPR682701A0 (en)	2001-08-30	Egf receptor
AU2002259188A1 (en)	2002-12-03	Recombinant simian gpr3 receptor
AU2002355833A1 (en)	2003-02-17	Tnf receptor 2 related protein variant

Legal Events

Date	Code	Title	Description
2004-08-05	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase